查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1859051

耐碳青霉烯类肠桿菌科细菌检测市场报告：趋势、预测及竞争分析（至2031年）

Carbapenem-Resistant Enterobacteriaceae Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

受医院和诊所市场机会的推动，全球耐碳青霉烯类肠桿菌检测市场前景广阔。预计2025年至2031年，该市场将以9.9%的复合年增长率成长。推动该市场成长的关键因素包括衣原体感染疾病发病率的上升、诊断技术的不断进步以及监管机构对感染控制日益重视。

  • Lucintel 预测，按类型划分，最低限度的感染控制措施预计将在预测期内实现高速成长。
  • 按用途划分，预计医院将高速成长。
  • 从区域来看，预计亚太地区在预测期内将达到最高成长。

碳青霉烯类抗药性肠桿菌科细菌检测市场的新趋势

受抗菌素抗药性带来的全球健康威胁的迫切影响，耐碳青霉烯类肠桿菌科细菌检测市场正经历快速变革。这些新兴趋势着重于提升诊断能力、简化工作流程，并提高耐碳青霉烯类肠桿菌科细菌检测的速度和可及性，以有效遏制其传播。

  • 快速分子诊断：目前快速分子诊断平台的发展趋势是能够在数小时而非数天内检测出碳青霉烯抗药性基因，从而能够快速识别碳青霉烯抗药性肠桿菌科细菌，进而快速实施感染控制措施并及时给予适当的抗生素，直接影响患者的治疗结果。
  • 即时检测：开发适用于照护现场（POC​​）的耐碳青霉烯类肠桿菌科细菌检测方案是新兴趋势。 POC 减少了将样本送到中心实验室的需求，并有助于在患者床边或小型诊所进行快速诊断。
  • 次世代定序用于监测：NGS 越来越多地用于对耐碳青霉烯类肠桿菌科分离株进行详细的基因组表征，以用于监测目的，从而能够精确识别抗药性机制、追踪传播途径和了解疫情的流行病学，这可以为遏制耐碳青霉烯类肠桿菌科传播的公共卫生策略提供资讯。
  • 多重检测：一个重要的趋势是采用多重检测技术，可以同时检测多种碳青霉烯酶基因和其他抗药性标记。这些检测方法可在单次检测中提供全面的信息，从而降低检测的复杂性，提高诊断效率，并有助于制定更明智的治疗决策。
  • 自动化和高通量系统：用于检测耐碳青霉烯类肠桿菌科细菌的自动化和高通量系统在临床实验室中越来越普遍。这一趋势旨在提高检测能力、减少人为错误并提高工作流程效率，使实验室能够处理更多检体并获得一致可靠的结果。

这些趋势从根本上重塑了耐碳青霉烯类肠桿菌科细菌检测市场，推动向更快、更便捷、更全面的诊断解决方案转变，从而加快临床决策，加强感染控制工作，支持强有力的监测，并最终为全球对抗抗菌素抗药性的斗争做出重大贡献。

碳青霉烯类抗药性肠桿菌科细菌检测市场的最新趋势

近年来，受抗生素抗药性日益严重的公共卫生威胁以及对提高诊断能力的迫切需求的推动，耐碳青霉烯类肠桿菌科细菌检测市场取得了多项重大进展。这些进展旨在提高耐碳青霉烯类肠桿菌科细菌检测的速度、准确性和可及性。

  • 快速分子检测的商业化：碳青霉烯抗药性肠桿菌科细菌的快速分子诊断检测的商业化和日益普及是一项关键进展。这些检测可在数小时内直接从临床检体中识别特定的碳青霉烯类抗生素基因（例如KPC、NDM、OXA-48），与传统的基于培养的方法相比，显着缩短了周转时间。
  • 新型表型检测方法的发展：近年来，碳青霉烯类抗生素灭活法（CIM）和改良的碳青霉烯类抗生素灭活法等新型表型分析方法相继问世。这些低成本、易于操作的检测方法正被临床实验室广泛采用，用于确认碳青霉烯类抗生素的产生并提供可靠的结果。
  • 对即时检测设备的关注日益增加：开发用于检测耐碳青霉烯类肠桿菌科细菌的近乎或完全即时检测设备已成为日益增长的趋势。儘管对于某些复杂目标而言，该技术仍处于起步阶段，但其重点在于提供床边快速检测结果，以便立即采取感染控制措施并启动治疗。
  • 与实验室自动化系统的整合：製造商越来越注重开发能够与现有实验室自动化系统无缝整合的耐碳青​​霉烯类肠桿菌科细菌检测解决方案，从而增强高通量能力，减少人工操作，最大限度地降低人为错误的风险，并提高整个实验室的效率和一致性。
  • 加强监测和报告平台：近期进展包括创建更先进的数位平台，用于即时监测和报告耐碳青霉烯类肠桿菌科细菌病例。这些平台正在帮助公共卫生机构监测抗药性趋势、识别疫情丛集，并实施有针对性的干预措施，以有效遏制耐碳青霉烯类肠桿菌科细菌的传播。

这些市场趋势共同影响耐碳青霉烯类肠桿菌科细菌检测市场，它们能够实现更快更准确的诊断，促进早期感染控制，提高不同环境下检测的可及性，简化实验室工作流程，并加强公共卫生监测，从而有助于更有效地应对抗菌素抗药性问题。

目录

第一章执行摘要

第二章 市场概览

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球耐碳青霉烯类肠桿菌科细菌检测市场（按类型划分）

  • 概述
  • 吸引力分析：按类型
  • 霍奇修正模型：趋势与预测（2019-2031）
  • 最低限度的感染抑制：趋势与预测（2019-2031 年）

5. 全球耐碳青霉烯类肠桿菌科细菌检测市场（依应用划分）

  • 概述
  • 吸引力分析：依目的
  • 医院：趋势与预测（2019-2031）
  • 诊所：趋势与预测（2019-2031 年）
  • 其他：趋势与预测（2019-2031 年）

第六章 区域分析

  • 概述
  • 全球碳青霉烯类抗药性肠桿菌科细菌检测市场（按地区划分）

7. 北美抗碳青霉烯类肠桿菌科细菌检测市场

  • 概述
  • 北美耐碳青霉烯类肠桿菌科细菌检测市场（按类型划分）
  • 北美耐碳青霉烯类肠桿菌科细菌检测市场（按应用领域划分）
  • 美国耐碳青霉烯类肠桿菌科细菌检测市场
  • 墨西哥耐碳青霉烯类肠桿菌科细菌检测市场
  • 加拿大耐碳青霉烯类肠桿菌科细菌检测市场

8. 欧洲耐碳青霉烯类肠桿菌检测市场

  • 概述
  • 欧洲耐碳青霉烯类肠桿菌科细菌检测市场（按类型划分）
  • 欧洲耐碳青霉烯类肠桿菌科细菌检测市场（依应用领域划分）
  • 德国耐碳青霉烯类肠桿菌科细菌检测市场
  • 法国耐碳青霉烯类肠桿菌科细菌检测市场
  • 西班牙耐碳青霉烯类肠桿菌科细菌检测市场
  • 义大利耐碳青霉烯类肠桿菌科细菌检测市场
  • 英国耐碳青霉烯类肠桿菌科细菌检测市场

9. 亚太地区抗碳青霉烯类肠桿菌科细菌检测市场

  • 概述
  • 亚太地区耐碳青霉烯类肠桿菌科细菌检测市场（按类型划分）
  • 亚太地区耐碳青霉烯类肠桿菌科细菌检测市场（依应用划分）
  • 日本耐碳青霉烯类肠桿菌科细菌检测市场
  • 印度耐碳青霉烯类肠桿菌科细菌检测市场
  • 中国耐碳青霉烯类肠桿菌科细菌检测市场
  • 韩国耐碳青霉烯类肠桿菌科细菌检测市场
  • 印尼耐碳青霉烯类肠桿菌科细菌检测市场

10. 世界其他地区（ROW）耐碳青霉烯类肠桿菌科细菌检测市场

  • 概述
  • ROW 碳青霉烯类抗药性肠桿菌科细菌检测市场（按类型划分）
  • ROW 碳青霉烯类抗药性肠桿菌科细菌检测市场（按应用划分）
  • 中东地区耐碳青霉烯类肠桿菌科细菌检测市场
  • 南美洲耐碳青霉烯类肠桿菌科细菌检测市场
  • 非洲耐碳青霉烯类肠桿菌科细菌检测市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 发展机会：透过申请
  • 全球耐碳青霉烯类肠桿菌科细菌检测市场新兴趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 企业合併、协议、合作关係和合资企业

第十三章：价值链中主要企业的概况

  • 竞争分析
  • TBA
  • SolGent
  • ELITechGroup
  • ALIFAX
  • BioMerieux

第十四章附录

  • 图表清单
  • 表格列表
  • 分析方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global carbapenem-resistant enterobacteriaceae testing market looks promising with opportunities in the hospital and clinic markets. The global carbapenem-resistant enterobacteriaceae testing market is expected to grow with a CAGR of 9.9% from 2025 to 2031. The major drivers for this market are the increasing incidence of cre infections, the rising advancements in diagnostic technologies, and the growing regulatory emphasis on infection control.

  • Lucintel forecasts that, within the type category, minimal inhibitory is expected to witness higher growth over the forecast period.
  • Within the application category, hospital is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market is undergoing dynamic changes, largely driven by the urgent global health threat posed by antimicrobial resistance. These emerging trends are focused on enhancing diagnostic capabilities, streamlining workflows, and improving the speed and accessibility of carbapenem-resistant enterobacteriaceae detection to combat its spread effectively.

  • Rapid Molecular Diagnostics: There's a strong trend towards rapid molecular diagnostic platforms capable of detecting carbapenems genes within hours, rather than days. This allows for quicker identification of carbapenem-resistant enterobacteriaceae, enabling faster implementation of infection control measures and timely administration of appropriate antibiotics, directly impacting patient outcomes.
  • Point-of-Care Testing: The development of carbapenem-resistant enterobacteriaceae testing solutions suitable for point-of-care settings is an emerging trend. POCT reduces the need for sending samples to centralized laboratories, facilitating quicker diagnosis at the patient's bedside or in smaller clinics, which is crucial for early intervention and preventing further transmission in various healthcare settings.
  • Next-Generation Sequencing for Surveillance: NGS is increasingly being utilized for detailed genomic characterization of carbapenem-resistant enterobacteriaceae isolates for surveillance purposes. This allows for precise identification of resistance mechanisms, tracking transmission routes, and understanding the epidemiology of outbreaks, informing public health strategies to contain the spread of carbapenem-resistant enterobacteriaceae.
  • Multiplex Assays: The adoption of multiplex assays capable of simultaneously detecting multiple carbapenemase genes and other resistance markers is a key trend. These assays offer comprehensive information from a single test, reducing testing complexity, improving diagnostic efficiency, and enabling more informed treatment decisions.
  • Automation and High-Throughput Systems: Automation and high-throughput systems are becoming more prevalent in clinical laboratories for carbapenem-resistant enterobacteriaceae testing. This trend aims to increase testing capacity, reduce manual errors, and improve workflow efficiency, allowing laboratories to process a larger volume of samples with consistent and reliable results.

These trends are fundamentally reshaping the carbapenem-resistant enterobacteriaceae testing market by driving towards faster, more accessible, and comprehensive diagnostic solutions. They enable quicker clinical decisions, enhance infection control efforts, support robust surveillance, and ultimately contribute significantly to the global fight against antimicrobial resistance.

Recent Developments in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market has recently witnessed several crucial developments, driven by the escalating public health threat of antibiotic resistance and the urgent need for improved diagnostic capabilities. These advancements are aimed at enhancing the speed, accuracy, and accessibility of carbapenem-resistant enterobacteriaceae detection.

  • Commercialization of Rapid Molecular Tests: A significant development is the commercialization and increased adoption of rapid molecular diagnostic tests for carbapenem-resistant enterobacteriaceae. These tests can identify specific carbapenems genes (e.g., KPC, NDM, OXA-48) directly from clinical samples in a few hours, drastically reducing turnaround time compared to traditional culture-based methods.
  • Development of Novel Phenotypic Assays: Recent years have seen the introduction of new phenotypic assays, such as carbapenem inactivation methods (CIM) and modified carbapenem inactivation methods. These low-cost, easy-to-perform tests are becoming more widely adopted for confirming carbapenems production in clinical laboratories, offering reliable results.
  • Increased Focus on Point-of-Care Devices: There's a growing trend in the development of near point-of-care or even true point-of-care devices for carbapenem-resistant enterobacteriaceae detection. While still in early stages for some complex targets, efforts are focused on providing rapid results at the bedside, enabling immediate infection control measures and treatment initiation.
  • Integration with Laboratory Automation Systems: Manufacturers are increasingly focusing on developing carbapenem-resistant enterobacteriaceae testing solutions that seamlessly integrate with existing laboratory automation systems. This enhances high-throughput capabilities, reduces manual labor, and minimizes the risk of human error, improving overall laboratory efficiency and consistency.
  • Enhanced Surveillance and Reporting Platforms: Recent developments include the creation of more sophisticated digital platforms for real-time surveillance and reporting of carbapenem-resistant enterobacteriaceae cases. These platforms aid public health agencies in monitoring resistance trends, identifying outbreak clusters, and implementing targeted interventions to control the spread of carbapenem-resistant enterobacteriaceae effectively.

These developments are collectively impacting the carbapenem-resistant enterobacteriaceae testing market by enabling faster and more accurate diagnosis, facilitating earlier infection control, improving accessibility of testing in diverse settings, streamlining laboratory workflows, and strengthening public health surveillance, all contributing to a more effective response against antimicrobial resistance.

Strategic Growth Opportunities in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market offers significant strategic growth opportunities across various key applications, driven by the escalating global burden of antimicrobial resistance and the critical need for rapid, accurate diagnostics. Capitalizing on these application-specific demands will be vital for market players.

  • Hospital and Clinical Diagnostics: The primary growth opportunity lies in equipping hospitals and clinical laboratories with advanced carbapenem-resistant enterobacteriaceae testing solutions. Rapid and accurate identification is crucial for timely patient management, preventing healthcare-associated infections, and implementing effective isolation protocols to contain outbreaks within healthcare facilities.
  • Infection Control and Surveillance Programs: Governments and healthcare organizations are investing heavily in national and regional infection control and surveillance programs. This presents a major growth opportunity for carbapenem-resistant enterobacteriaceae testing, as diagnostics are fundamental for monitoring resistance trends, identifying high-risk areas, and guiding public health interventions.
  • Pharmaceutical and Biotech R&D: The development of new antibiotics and therapeutic strategies against carbapenem-resistant enterobacteriaceae requires extensive testing during preclinical and clinical trials. This creates a niche but significant growth opportunity for specialized carbapenem-resistant enterobacteriaceae testing services and kits that can accurately assess the efficacy of novel antimicrobial compounds.
  • Veterinary Diagnostics: While human health is the primary focus, the "One Health" approach recognizes the link between human and animal health. Growing awareness of antimicrobial resistance in livestock and companion animals presents an emerging opportunity for carbapenem-resistant enterobacteriaceae testing in veterinary diagnostics to monitor and control resistance spread.
  • Point-of-Care and Decentralized Testing: The push for decentralized healthcare and rapid decision-making creates opportunities for compact, easy-to-use carbapenem-resistant enterobacteriaceae testing devices suitable for smaller clinics, emergency rooms, or even remote settings. This expands accessibility and reduces turnaround times, crucial for immediate patient management and infection control.

These strategic growth opportunities are profoundly impacting the carbapenem-resistant enterobacteriaceae testing market by driving the development of specialized and versatile diagnostic solutions tailored to the unique needs of each application. This leads to increased innovation, diversified product portfolios, and expanded market reach, ultimately strengthening the global response to antimicrobial resistance.

Carbapenem-Resistant Enterobacteriaceae Testing Market Driver and Challenges

The carbapenem-resistant enterobacteriaceae testing market's trajectory is shaped by a complex interplay of various technological, economic, and regulatory factors. Major drivers stem from the urgent global health threat of antimicrobial resistance, while challenges include high testing costs, the technical complexity of emerging methods, and stringent regulatory pathways.

The factors responsible for driving the carbapenem-resistant enterobacteriaceae testing market include:

1. Rising Global Incidence of carbapenem-resistant enterobacteriaceae Infections: The escalating prevalence of carbapenem-resistant enterobacteriaceae infections worldwide is the most significant driver. These "superbugs" cause severe, often untreatable infections, leading to higher morbidity and mortality rates, thereby creating an urgent and growing demand for rapid and accurate diagnostic tools to combat their spread.

2. Increasing Awareness and Surveillance Initiatives: Greater awareness among healthcare professionals and the public about the dangers of carbapenem-resistant enterobacteriaceae, coupled with increased national and international surveillance programs, is driving market growth. These initiatives emphasize early detection and reporting, boosting the demand for effective testing solutions to monitor and control resistance.

3. Technological Advancements in Diagnostics: Continuous innovation in diagnostic technologies, particularly in molecular assays (PCR, NGS) and automated phenotypic methods, is a key driver. These advancements offer improved sensitivity, specificity, and faster turnaround times, enabling more precise and timely identification of carbapenem-resistant enterobacteriaceae, which directly impacts treatment decisions.

4. Growing Healthcare Expenditure: Increased healthcare spending, particularly in developing nations, contributes to market expansion. As healthcare infrastructure improves and access to advanced diagnostics becomes more widespread, there's a greater capacity and willingness to invest in carbapenem-resistant enterobacteriaceae testing technologies to improve patient outcomes and infection control.

5. Antimicrobial Stewardship Programs: The global push for antimicrobial stewardship programs aims to optimize antibiotic use and curb resistance. carbapenem-resistant enterobacteriaceae testing plays a critical role by guiding appropriate antibiotic selection, preventing empirical broad-spectrum treatment, and supporting infection control measures, thereby fostering responsible antibiotic use.

Challenges in the carbapenem-resistant enterobacteriaceae testing market are:

1. High Cost of Advanced Technologies: The significant upfront cost of advanced molecular diagnostic platforms and reagents can be a major challenge, especially for healthcare facilities in resource-limited settings. This high investment can limit widespread adoption, despite the clinical benefits of rapid and accurate carbapenem-resistant enterobacteriaceae detection.

2. Technical Complexity and Skilled Personnel: Many advanced carbapenem-resistant enterobacteriaceae testing methods, particularly molecular and genomic techniques, require specialized equipment, complex protocols, and highly trained laboratory personnel for accurate execution and interpretation. A shortage of skilled staff can hinder the effective implementation and widespread use of these diagnostics.

3. Regulatory and Reimbursement Hurdles: The development and commercialization of new carbapenem-resistant enterobacteriaceae diagnostic tests face stringent regulatory approval processes, which can be time-consuming and costly. Additionally, securing adequate reimbursement from healthcare payers for these tests can be a challenge, impacting their market penetration and accessibility.

These drivers and challenges on the carbapenem-resistant enterobacteriaceae testing market is a dynamic push for more rapid, accurate, and accessible diagnostics to combat the escalating threat of antimicrobial resistance. However, overcoming the hurdles of cost, technical complexity, and regulatory pathways remains critical for achieving widespread adoption and maximizing the public health benefit of these essential tests.

List of Carbapenem-Resistant Enterobacteriaceae Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies carbapenem-resistant enterobacteriaceae testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the carbapenem-resistant enterobacteriaceae testing companies profiled in this report include-

  • TBA
  • SolGent
  • ELITechGroup
  • ALIFAX
  • BioMerieux

Carbapenem-Resistant Enterobacteriaceae Testing Market by Segment

The study includes a forecast for the global carbapenem-resistant enterobacteriaceae testing market by type, application, and region.

Carbapenem-Resistant Enterobacteriaceae Testing Market by Type [Value from 2019 to 2031]:

  • Modified Hodge
  • Minimal Inhibitory

Carbapenem-Resistant Enterobacteriaceae Testing Market by Application [Value from 2019 to 2031]:

  • Hospitals
  • Clinics
  • Others

Carbapenem-Resistant Enterobacteriaceae Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market is experiencing robust growth driven by the escalating global prevalence of these highly resistant "nightmare bacteria" and the urgent need for rapid, accurate diagnostics. Recent developments focus on improving detection speed, specificity, and accessibility of testing, crucial for timely treatment and effective infection control. This evolution is underpinned by a global commitment to combating antimicrobial resistance and enhancing public health surveillance.

  • United States: The US market is characterized by a strong emphasis on rapid molecular diagnostics and advanced automated systems for carbapenem-resistant enterobacteriaceae detection, driven by the CDC's focus on antimicrobial resistance. Significant investment in R&D aims to provide faster turnaround times for results, crucial for managing outbreaks and guiding appropriate treatment in healthcare settings.
  • China: China carbapenem-resistant enterobacteriaceae testing market is rapidly expanding due to increasing awareness, growing healthcare expenditure, and a rising incidence of antibiotic-resistant infections. There's a dual focus on developing indigenous diagnostic solutions and adopting international technologies to strengthen its capacity for rapid and accurate carbapenem-resistant enterobacteriaceae identification.
  • Germany: Germany market for carbapenem-resistant enterobacteriaceae testing prioritizes high-quality, reliable diagnostic platforms, integrating seamlessly with its advanced healthcare infrastructure. Developments include sophisticated molecular assays and phenotypic tests, supporting comprehensive antimicrobial stewardship programs and robust surveillance efforts to control resistance.
  • India: India carbapenem-resistant enterobacteriaceae testing market is witnessing significant growth, spurred by a large patient population, improving healthcare facilities, and a growing burden of antibiotic resistance. There's an increasing demand for cost-effective and rapid diagnostic solutions, including both conventional and molecular methods, to address the challenge of carbapenem-resistant enterobacteriaceae in diverse clinical settings.
  • Japan: Japan carbapenem-resistant enterobacteriaceae testing market emphasizes precision and technological innovation, with a focus on advanced molecular diagnostics for rapid identification of carbapenems genes. Developments are geared towards highly sensitive and specific tests to support strict infection control measures and facilitate prompt, targeted treatment strategies in its healthcare system.

Features of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market

  • Market Size Estimates: Carbapenem-resistant enterobacteriaceae testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Carbapenem-resistant enterobacteriaceae testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Carbapenem-resistant enterobacteriaceae testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, applications, and regions for the carbapenem-resistant enterobacteriaceae testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the carbapenem-resistant enterobacteriaceae testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the carbapenem-resistant enterobacteriaceae testing market by type (modified hodge and minimal inhibitory), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Modified Hodge: Trends and Forecast (2019-2031)
  • 4.4 Minimal Inhibitory: Trends and Forecast (2019-2031)

5. Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals: Trends and Forecast (2019-2031)
  • 5.4 Clinics: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Region

7. North American Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 7.1 Overview
  • 7.2 North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 7.3 North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 7.4 United States Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 7.5 Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 7.6 Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market

8. European Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 8.1 Overview
  • 8.2 European Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 8.3 European Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 8.4 German Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.5 French Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.6 Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.7 Italian Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.8 United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market

9. APAC Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 9.1 Overview
  • 9.2 APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 9.3 APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 9.4 Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.5 Indian Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.6 Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.7 South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.8 Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market

10. ROW Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 10.1 Overview
  • 10.2 ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 10.3 ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 10.4 Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 10.5 South American Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 10.6 African Carbapenem-Resistant Enterobacteriaceae Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 TBA
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 SolGent
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 ELITechGroup
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 ALIFAX
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 BioMerieux
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.1: Usage of Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.2: Classification of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.3: Supply Chain of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 3.1: Driver and Challenges of the Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.1: Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.1: European Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 8.4: European Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.1: APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.1: ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Carbapenem-Resistant Enterobacteriaceae Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Carbapenem-Resistant Enterobacteriaceae Testing Market by Region
  • Table 1.3: Global Carbapenem-Resistant Enterobacteriaceae Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.4: Trends of Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.5: Forecast for Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.6: Trends of Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.7: Forecast for Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.4: Trends of Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.5: Forecast for Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.6: Trends of Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.7: Forecast for Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.1: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.1: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.2: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 11.1: Product Mapping of Carbapenem-Resistant Enterobacteriaceae Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of Carbapenem-Resistant Enterobacteriaceae Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Carbapenem-Resistant Enterobacteriaceae Testing Revenue
  • Table 12.1: New Product Launches by Major Carbapenem-Resistant Enterobacteriaceae Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market